News Quantified

GLYC – glycomimetics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

-4.1%

BEAT

-10.4%

MISS

7.1%

BEAT

Form 8-K GLYCOMIMETICS INC For: Dec 19

Form SC 13G GLYCOMIMETICS INC Filed by: Logos Global Management LP

Form 10-Q GLYCOMIMETICS INC For: Sep 30

Form SC 13G/A GLYCOMIMETICS INC Filed by: Invus Global Management, LLC

Form DEFA14A GLYCOMIMETICS INC

Top News Gainers

9/9 Form SC 13G/A GLYCOMIMETICS INC Filed by: BIOTECHNOLOGY VALUE FUND L P 14.1%

4/9 Form SC 13G/A GLYCOMIMETICS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP 13.2%

8/15 Form 4 GLYCOMIMETICS INC For: Aug 13 Filed by: JUNIUS DANIEL M 11.5%

8/5 GlycoMimetics Inc (NASDAQ: GLYC) had its price target lowered by analysts at HC Wainwright from $23.00 to $18.00. They now have a "buy" rating on the stock. 9.6%

1/6 Form 4 GLYCOMIMETICS INC For: Jan 06 Filed by: Magnani John L. 6.5%

9/5 GlycoMimetics to Present at Two Upcoming Investor Conferences 6.1%

11/7 GlycoMimetics Inc (NASDAQ: GLYC) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 6.0%

10/31 GlycoMimetics to Report Third Quarter 2019 Financial Results on November 7, 2019 5.3%

5/4 GlycoMimetics (GLYC) Q1 2019 Earnings Call Transcript [The Motley Fool] 5.2%

11/13 GlycoMimetics to Present at Two Upcoming Investor Conferences 5.0%

Top News Decliners

8/4 GlycoMimetics Inc (NASDAQ: GLYC) was downgraded by analysts at Piper Jaffray Companies from an "overweight" rating to a "neutral" rating. -46.7%

11/21 Form 8-K GLYCOMIMETICS INC For: Nov 21 -16.9%

4/28 GlycoMimetics Inc (NASDAQ: GLYC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -8.2%

11/16 GlycoMimetics Inc (NASDAQ: GLYC) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. -8.0%

11/21 GlycoMimetics Inc (NASDAQ: GLYC) had its price target lowered by analysts at Roth Capital from $12.00 to $9.00. -7.1%

6/10 Form SC 13G GLYCOMIMETICS INC Filed by: Invesco Ltd. -7.1%

1/24 Form 4 GLYCOMIMETICS INC For: Jan 22 Filed by: King Rachel K. -6.1%

7/24 GlycoMimetics Inc (NASDAQ: GLYC) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -6.0%

1/7 Form 8-K GLYCOMIMETICS INC For: Jan 02 -5.7%

11/9 GlycoMimetics' (GLYC) CEO Rachel King on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] -5.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day